Atlas Trials

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Clinical trial NCT00199875 · COMPLETED

Trial details

NCT number
NCT00199875
Sponsor
Ludwig Institute for Cancer Research
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell CarcinomaKidney NeoplasmRenal CancerKidney Cancer
Start date
2005-07-06
Primary completion
2013-03-14
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.